Lack of effect of simultaneously administered didanosine encapsulated enteric bead formulation (Videx EC) on oral absorption of indinavir, ketoconazole, or ciprofloxacin

Antimicrobial Agents and Chemotherapy

Volumn 46, Issue 2, 2002, Pages 385-391

  Damle, Bharat D ^a   Mummaneni, Vanaja ^a   Kaul, Sanjeev ^a   Knupp, Catherine ^a  

^a BRISTOL MYERS SQUIBB PHARMACEUTICAL RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTACID AGENT; CIPROFLOXACIN; DIDANOSINE; INDINAVIR; KETOCONAZOLE; VIDEX EC;

ADULT; AREA UNDER THE CURVE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE TIME EFFECT RELATION; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG COMPETITION; DRUG HALF LIFE; ENTERIC COATED TABLET; FEMALE; HUMAN; MALE; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TABLET FORMULATION;

ABSORPTION; ADMINISTRATION, ORAL; ADOLESCENT; ADULT; ANTI-INFECTIVE AGENTS; ANTIFUNGAL AGENTS; ANTIMETABOLITES; CAPSULES; CHEMISTRY, PHARMACEUTICAL; CIPROFLOXACIN; CROSS-OVER STUDIES; DIDANOSINE; DRUG INTERACTIONS; DRUG TOLERANCE; FEMALE; HIV PROTEASE INHIBITORS; HUMANS; INDINAVIR; KETOCONAZOLE; MALE; MIDDLE AGED;

EID: 0036148655     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.46.2.385-391.2002     Document Type: Article

References (23)

1. Preformulation solubility and kinetic studies of 2′,3′-dideoxynucleosides: Potential anti-AIDS agents
2. Pharmacokinetics of ciprofloxacin in the elderly
3. Increased gastric pH and the bioavailability of fluconazole and ketoconazole
4. Effect of pH on disintegration and dissolution of ketoconazole tablets
5. High-performance liquid chromatographic determination of a potent and selective HIV protease inhibitor (L-735,524) in rat, dog and monkey plasma
6. Clinical pharmacokinetics of ketoconazole
7. Influence of food on the pharmacokinetics of ketoconazole
8. The clinical pharmacokinetics of levofloxacin
9. Effects of aluminum hydroxide and calcium carbonate antacids on the bioavailability of ciprofloxacin
10. Pharmacokinetics and dose proportionality of ketoconazole in normal volunteers
11. Pharmacokinetics of didanosine and ketoconazole after coadministration to patients seropositive for the human immunodeficiency virus
12. Pharmacokinetics of didanosine in patients with acquired immunodeficiency syndrome-related complex
13. 2 blockers
14. pH-dependent oral absorption of L-735,524, a potent HIV protease inhibitor, in rats and dogs
15. Pharmacokinetics of gatifloxacin and interaction with an antacid containing aluminum and magnesium
16. Absorption interactions with fluoroquinolones
17. Effect of simultaneous didanosine administration on itraconazole absorption in healthy volunteers
18. Didanosine: An update on its antiviral activity, pharmacokinetic properties and therapeutic efficacy in the management of HIV disease
19. Drug-drug interactions with ciprofloxacin and other fluoroquinolones
20. Cations in the didanosine tablet reduce ciprofloxacin bioavailability
21. Evaluation of the influence of antacids and H2 antagonists on the absorption of moxifloxacin after oral administration of a 400-mg dose to health volunteers
22. Measurement of ketoconazole, a new antifungal agent, by high-performance liquid chromatography
23. Determination of ciprofloxacin in biological samples by high performance liquid chromatography